Gujarat Kidney And Super Speciality Limited (GKSL) Financial Results — Revenue ₹3,129.17 Cr

Revenue: ₹3,129.17 CrNet Profit: ₹482.6 Cr

📢 Key Event
Board approved audited financial results and appointed internal and secretarial auditors for FY 2026-27.

🔄 What Changed
Revenue grew 105.5% YoY to ₹8,288.60 lakhs; profit after tax reached ₹1,681.18 lakhs; EPS was ₹0.81; cash and cash equivalents ended at ₹1,328.24 lakhs.

💡 Investor Takeaway
The company delivered strong revenue growth and profitability with audited results confirmed, signaling positive financial momentum for shareholders.

Gujarat Kidney And Super Speciality Limited reported consolidated revenue of ₹8,288.60 lakhs and profit after tax of ₹1,681.18 lakhs for the year ended March 31, 2026, reflecting a 105.5% YoY revenue growth and a 20.28% profit margin, with earnings per share at [amount context mismatch] and total comprehensive income of ₹491.34 lakhs, supported by an unmodified auditor opinion and compliance with SEBI regulations, while cash and cash equivalents stood at ₹1,328.24 lakhs at year-end.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GKSL ✨ Ask AI About This